Cited by 596Neuroscience and Neuropharmacology ResearchNeurogenesis and neuroplasticity mechanismsNeurological Disease Mechanisms and Treatments

The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index; none of the 18 sources its claims cite is checked for support yet.

Oligodendroglial NMDA Receptors Regulate Glucose Import and Axonal Energy Metabolism

Open access

Abstract

SUMMARY Oligodendrocytes make myelin and support axons metabolically with lactate. However, it is unknown how glucose utilization and glycolysis are adapted to the different axonal energy demands. Spiking axons release glutamate and oligodendrocytes express NMDA receptors of unknown function. Here we show that the stimulation of oligodendroglial NMDA receptors mobilizes glucose transporter GLUT1, leading to its incorporation into the myelin compartment in vivo. When myelinated optic nerves from conditional NMDA receptor mutants are challenged with transient oxygen-glucose deprivation, they show a reduced functional recovery when returned to oxygen-glucose but are indistinguishable from wild-type when provided with oxygen-lactate. Moreover, the functional integrity of isolated optic nerves, which are electrically silent, is extended by preincubation with NMDA, mimicking axonal activity, and shortened by NMDA receptor blockers. This reveals a novel aspect of neuronal energy metabolism in which activity-dependent glutamate release enhances oligodendroglial glucose uptake and glycolytic support of fast spiking axons.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

Oligodendroglial NMDA receptor activation mobilizes GLUT1 to the cell surface/myelin and increases glucose import and lactate release, coupling axonal spiking to oligodendroglial glycolytic support. Conditional NR1 loss reduces myelin GLUT1, impairs recovery from oxygen-glucose deprivation unless lactate is supplied, and causes late axonal and neurological deficits.

Key findings

  • In cultured oligodendrocytes, NMDA triggered GLUT1 surface redistribution within 30 min, blocked by D-AP5; biotinylation showed a 2-fold surface GLUT1 increase, FRET glucose sensor measurements rose from 0.56 ± 0.04 mM at baseline to 1.85 ± 0.24 mM after NMDA, and NMR showed a 24% ± 4% increase in U-13C-lactate release; MCT1 was unchanged.
  • In Grin1flox/flox*Cnp1Cre/+ (NR1 cKO) optic nerves, myelin GLUT1 was reduced by 80%, recombination reached 62% ± 8% at P96, and myelin was transiently thinner at P18–P20 but normal at P70.
  • After 60-min oxygen-glucose deprivation, NR1 mutant optic nerves recovered 50% less than controls; lactate reperfusion restored recovery equal to or better than glucose; wild-type nerves preincubated 16 hr with NMDA/Gly maintained high-frequency conduction better, while D-AP5/7CKA worsened it, and without NMDA, 25 Hz stimulation caused about 10% decline per min.
  • Adult NR1 mutants showed faster high-frequency spinal CAP amplitude drop and slower recovery, a 1-year rotarod deficit, and at 19 months a severe neurological phenotype including hind limb clasping, hunchback, and ataxia with neuroinflammation and axonopathy in white matter tracts.

Methods

  • Conditional NR1 knockout mice (Grin1flox/flox*Cnp1Cre/+) versus controls, plus primary mouse/rat OPC cultures and immunopanned oligodendrocytes; assays included immunocytochemistry, surface biotinylation, FRET glucose sensor imaging, 2-deoxyglucose uptake, NMR lactate release, myelin purification/immunoblot, immunogold EM, optic nerve CAP recordings with OGD and graded frequency, in vivo spinal cord CAP recordings, rotarod, and clinical scoring.
  • Statistics used Mann-Whitney, two-tailed Student’s t tests, one-way or two-way ANOVA with Bonferroni post-test, or linear mixed effects models; significance was set at *p < 0.05, p < 0.01, *p < 0.001, with data as means ± SEM.

Limitations

  • Stated: astrocytes may compensate some metabolic functions in oligodendroglial NMDA receptor mutants; acute ex vivo NMDA receptor blockade did not visibly reduce recovery from OGD, which the authors attribute to different timescales between development and pharmacology; some mechanistic data (insulin mobilization, microtubule dependence) are “data not shown.”
  • Evident: findings rely on rodent optic nerve/spinal cord and cultured oligodendrocytes; axonal energy metabolism is inferred from conduction recovery and lactate rescue rather than direct ATP measurement; no human data are presented.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2016.05.016

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 18 cited sources checked · 0 supported · 0 flagged

Show all 51 claims

  • It may state two separate claims as one. 26
  • The quote only partly states this claim. 4
  • Probably not a substantial claim. 9
33 of 33
  • The paper relies on this without support.

    The average spike count rate is the key determinant of axonal ATP consumption.

    “Since the average spike count rate is the key determinant of axonal ATP consumption”
  • The paper relies on this without support.

    Constitutive overproduction of lactate would result in lactic acidosis detrimental for white matter function.

    “The constitutive overproduction of lactate would result in lactic acidosis, detrimental for white matter function.”
  • The paper relies on this without support.

    Oligodendrocytes need to know the spiking activity of myelinated axons to adapt their own energy metabolism.

    “oligodendrocytes need to “know” the spiking activity of myelinated axons”
3 of 3

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 60 references

Cited by

Sorted by citations

Items 501–596 of 596

Metadata

Authors
Saab, A. S., Tzvetavona, I. D., Trevisiol, A., Baltan, S., Dibaj, P., Kusch, K., Möbius, W., Goetze, B., Jahn, H. M., Huang, W., Steffens, H., Schomburg, E. D., Pérez-Samartín, A., Pérez-Cerdá, F., Bakhtiari, D., Matute, C., Löwel, S., Griesinger, C., Hirrlinger, J., Kirchhoff, F., & Nave, K.-A.
Affiliations
  • University of Zurich (CH)
  • Max Planck Institute of Experimental Medicine (DE)
  • Cleveland Clinic (US)
  • Nanoscale Microscopy and Molecular Physiology of the Brain Cluster of Excellence 171 — DFG Research Center 103 (DE)
  • University of Göttingen (DE)
  • Max Planck Institute for Biophysical Chemistry (DE)
  • University of the Basque Country (ES)
Corresponding author
  • Kirchhoff, Frank
  • Nave, Klaus-Armin
Venue
Neuron
Publisher
Elsevier BV
Published
2016-07
Volume
91
Issue
1
Pages
119-132
ISSN
0896-6273 (ISSN-L)
OpenAlex
W2419165202
Cited by
590
References
60
Citations by year
2026: 48 · 2025: 68 · 2024: 80 · 2023: 61 · 2022: 65 · 2021: 73 · 2020: 58 · 2019: 41 · 2018: 41 · 2017: 45 · 2016: 9
FWCI
25.51
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • PubMed Central (acceptedVersion)
  • GRO (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
National Institute on Aging (R56AG033720, R01AG033720)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
glucose uptake, GLUT1, axonal energy metabolism, myelin, optic nerve, oxygen-glucose deprivation, lactate, glycolysis, glutamate release, myelination
MeSH terms
Animals, Axons, Energy Metabolism, Glucose, Mice, Transgenic, Myelin Sheath, Oligodendroglia, Optic Nerve, Oxygen, Receptors, N-Methyl-D-Aspartate, Glucose Transporter Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review